Company: CMND
Filing Date: 2025-03-13
Form Type: POS AM
Source: 0001213900-25-023708
Chunk: 35

Company: Clearmind Medicine Inc.
Filing Date: 2025-03-13
Form: POS AM
Chunk 35
---
 the selling shareholders without registration and without regard
to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for us to be in compliance with the current
public information under Rule 144 under the Securities Act or any other rule of similar effect or (ii) all of the securities have been
sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule of similar effect. The resale securities will
be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in certain
states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable
state or an exemption from the registration or qualification requirement is available and is complied with.

Under applicable rules and regulations under the
Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously engage in market making activities
with respect to the common shares for the applicable restricted period, as defined in Regulation M, prior to the commencement of the
distribution. In addition, the selling shareholders will be subject to applicable provisions of the Exchange Act and the rules and regulations
thereunder, including Regulation M, which may limit the timing of purchases and sales of the common shares by the selling shareholders
or any other person. We will make copies of this prospectus available to the selling shareholders and have informed them of the need
to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule 172 under
the Securities Act).

<div align='center'>EXPENSES OF THIS OFFERING</div>

Set forth below is an itemization of the total
expenses, excluding placement agent discounts, expected to be incurred in connection with the offer and sale of the securities offered
by us. With the exception of the SEC registration fee, all amounts are estimates:

| SEC registration fee         |     | $ |    315 |
| Legal fees and expenses      |     |   | 25,000 |
| Accounting fees and expenses |     |   |  5,000 |
| Miscellaneous                |     |   |  5,000 |
| Total                        |     | $ | 35,315 |

<div align='center'>LEGAL MATTERS</div>

The validity of the issuance of our Common Shares
offered in this prospectus and certain other matters of Canadian law will be passed upon for us by Daniel N. Bloch. Certain matters of
U